Targeted Neurocare Small clinic with a specialized MeRT approach blending TMS and qEEG to treat autism and other neurological conditions presents a prime opportunity to partner with larger multi-site networks seeking high-demand, nonpharmacological therapies to augment their neurology and psychiatry portfolios.

Expansion Potential Revenue under one million signals a growth-ready partner for distribution, integration, or revenue-sharing arrangements with mid-sized health systems or regional networks aiming to broaden their brain health services without large CapEx commitments.

Tech-Driven Care Proprietary or specialized device-based protocol positions the company to explore technology partnerships, telehealth-enabled follow-ups, data analytics collaborations, or equipment leasing agreements with clinics looking to modernize their neuromodulation offerings.

Strategic Alignments Comparable institutions in the market feature large workforce and high revenue; this gap suggests a potential channel strategy to align with larger hospital groups for referrals, joint marketing, or managed service arrangements to scale MeRT adoption.

Clinical Market Fit Focus on autism, depression, anxiety, concussion and PTSD indicates opportunities to target specialty clinics, behavioral health networks, and veteran care programs that prioritize advanced neuromodulation therapies and personalized brain health protocols.